Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; 7 of the 20 sources its claims cite were checked for support.
Abstract
OBJECTIVE: To assess the effectiveness of structured blood glucose testing in poorly controlled, noninsulin-treated type 2 diabetes. RESEARCH DESIGN AND METHODS: This 12-month, prospective, cluster-randomized, multicenter study recruited 483 poorly controlled (A1C ≥7.5%), insulin-naïve type 2 diabetic subjects from 34 primary care practices in the U.S. Practices were randomized to an active control group (ACG) with enhanced usual care or a structured testing group (STG) with enhanced usual care and at least quarterly use of structured self-monitoring of blood glucose (SMBG). STG patients and physicians were trained to use a paper tool to collect/interpret 7-point glucose profiles over 3 consecutive days. The primary end point was A1C level measured at 12 months. RESULTS: The 12-month intent-to-treat analysis (ACG, n = 227; STG, n = 256) showed significantly greater reductions in mean (SE) A1C in the STG compared with the ACG: −1.2% (0.09) vs. −0.9% (0.10); Δ = −0.3%; P = 0.04. Per protocol analysis (ACG, n = 161; STG, n = 130) showed even greater mean (SE) A1C reductions in the STG compared with the ACG: −1.3% (0.11) vs. −0.8% (0.11); Δ = −0.5%; P < 0.003. Significantly more STG patients received a treatment change recommendation at the month 1 visit compared with ACG patients, regardless of the patient’s initial baseline A1C level: 179 (75.5%) vs. 61 (28.0%); <0.0001. Both STG and ACG patients displayed significant (P < 0.0001) improvements in general well-being (GWB). CONCLUSIONS: Appropriate use of structured SMBG significantly improves glycemic control and facilitates more timely/aggressive treatment changes in noninsulin-treated type 2 diabetes without decreasing GWB.
Overview
CoChat Summary
TL;DR
In poorly controlled, insulin-naïve type 2 diabetes, structured self-monitoring of blood glucose (SMBG) plus enhanced usual care reduced A1C significantly more than enhanced usual care alone over 12 months. It also produced more timely treatment changes without decreasing general well-being.
Key findings
- In the intent-to-treat analysis (ACG n = 227; STG n = 256), mean (SE) A1C reductions were −1.2% (0.09) for STG vs. −0.9% (0.10) for ACG; Δ = −0.3%; P = 0.04. Per-protocol reductions were −1.3% (0.11) vs. −0.8% (0.11); Δ = −0.5%; P < 0.003.
- Significantly more STG patients received a treatment change recommendation at month 1: 179 (75.5%) vs. 61 (28.0%); P < 0.0001. Mean (SD) scheduled visits with a treatment change recommendation were 2.7 (1.5) vs. 1.1 (1.0); P < 0.0001. More STG patients started intermediate- or long-acting insulin: 42 vs. 23; P = 0.046.
- STG subjects showed reduced preprandial-to-postprandial glucose excursions from month 1 to month 12: breakfast 44 to 35 mg/dL (P < 0.005), lunch 25 to 17 mg/dL (P < 0.03), supper 34 to 26 mg/dL (P < 0.05). Mean amplitude of glucose excursions fell from 38.5 (0.9) to 34.3 (1.0) mg/dL (P = 0.0003).
- General well-being improved in both groups (ACG P < 0.007; STG P < 0.0001), with no significant between-group difference over time; per-protocol adherent STG subjects had greater improvement than adherent ACG subjects (P < 0.04).
Methods
- 12-month prospective, cluster-randomized, multicenter study in 34 U.S. primary care practices randomized to active control (ACG, n = 13 practices) or structured testing (STG, n = 21 practices); 483 poorly controlled (A1C ≥7.5%), insulin-naïve type 2 diabetes patients were included in the intent-to-treat cohort (ACG n = 227; STG n = 256).
- STG patients and physicians used the Accu-Chek 360° View tool to collect/interpret 7-point glucose profiles over 3 consecutive days before scheduled visits; ACG received enhanced usual care only. Primary endpoint was A1C at 12 months.
- Linear mixed models compared groups over time, controlling for baseline A1C, age, gender, and race as fixed effects and practice site and subject as random effects; intent-to-treat and per-protocol analyses were performed.
Limitations
- Stated: no third study arm assessed the effect of increased attention in both groups; the study could not determine whether treatment changes were clinically appropriate, because it measured number rather than type of change; it could not determine how many recommended changes actually occurred; and STG had greater attrition than ACG (not statistically significant), possibly reflecting intervention burden and biasing findings.
- Evident from the text: the ACG received enhanced usual care, free meters/strips, and more frequent visits, so between-group differences may be conservative; per-protocol results depend on adherence definitions and exclusion of nonadherent STG patients, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
4 Valid · 1 Not valid · 4 Not checked · 51 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Inconsistent findings seen in studies of insulin-naïve type 2 diabetic patients may be due, in part, to differences in key design issues, such as subject selection criteria (e.g., whether or not patients had poor glycemic control at study entry), critical content differences in the actual SMBG intervention (e.g., whether physicians were privy to patient SMBG data), fidelity of treatment delivery (”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > Abstract > CONCLUSIONS
What the sources say
- Supportedcites [14] Polonsky, 2010, The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with type 2 diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986], BMC Fam Pract source
The Background summary says that differences in SMBG protocols and study designs have left findings in insulin-naïve type 2 diabetes unclear. Its sections on baseline HbA1c, HCP use of SMBG data, and completion of the prescribed protocol address subject selection, intervention content and delivery, and adherence. Page numbers are not available in our copy. (LLM, conf=0.93)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Measurements of mean amplitude of glucose excursions indicated significant (P = 0.0003) mean (SE) reductions in glycemic variability among STG subjects from 38.5 mg/dL (0.9) at month 1 to 34.3 mg/dL (1.0) at month 12.”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > Seven-point blood glucose profile findings
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There were no changes in these findings when insulin-using patients were excluded from the analyses.”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > Seven-point blood glucose profile findings
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“PP analyses revealed that adherent STG subjects reported a significantly greater improvement in GWB than adherent ACG subjects (P < 0.04).”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > General well-being
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similar between-group differences occurred using last observation carried forward analysis (last A1C before insulin start carried forward): −1.0% (0.10) vs. −0.7% (0.10); Δ = −0.3%; P = 0.03.”
§ Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes > RESULTS > Changes in treatment
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
25 more claims
Create a free account to see all 60 claims and to verify the 2 references still open.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“per protocol analysis of the STeP study showed a significant between-group difference, favoring sSMBG, for general emotional well-being (WHO-5), regimen-related diabetes distress (DDS subscale), and diabetes-specific self-efficacy (CIDS) (61, 62, 64).”
From The impact of structured self-monitoring of blood glucose on clinical, behavioral, and psychosocial outcomes among adults with non-insulin-treated type 2 diabetes: a systematic review and meta-analysis (2023) · cites this paper as [61]
Experimental — accuracy not yet measuredIn the citing paper
“In a year-long study of insulin-naive people with diabetes with suboptimal initial glycemic outcomes, a group trained in structured BGM (a paper tool was used at least quarterly to collect and interpret seven-point BGM profiles taken on three consecutive days) reduced their A1C levels by 0.3% more than the control group (32).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [32]
In the citing paper
“To optimally benefit from structured SMBG, the obtained BG values therefore have to be actively used by PwD or healthcare professionals (HCPs) for therapeutic decisions or therapy adjustments, such as changes in eating behavior, lifestyle and/or anti-diabetic therapy [9].”
From Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus (2022) · cites this paper as [9]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
(2004) · Choice Reviews Online · doi:10.5860/choice.42-2265 · Cited by 1,384
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
Bech, P., Olsen, L. R., Kjoller, M., & Rasmussen, N. K. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.145 · Cited by 1,015 · cited 1×
“GWBwas measured using theWHO-5 Well-Being Index assessment tool (17), a widely used, five-item questionnaire with a total score range of from 0–100 (higher scores indicatingmorepositivewell-being).”
Method(2007) · Endocrine Practice · doi:10.4158/ep.13.s1.1 · Cited by 699
Cited by
Items 301–400 of 426
Jinnouchi, H., Yoshida, A., Taniguchi, M., Yamauchi, E., Kurosawa, D., Yachiku, K., Minoura, I., Kadowaki, T., Yamauchi, T., Aihara, M., et al. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01599-2 · Cited by 3
Fisher, L., Fortmann, A. L., Knaebel, J., & Stuhr, A. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221096163 · Cited by 3
Self-citationBlood glucose monitoring: an overview
Whitmore, C. (2012) · British Journal of Nursing · doi:10.12968/bjon.2012.21.10.583 · Cited by 3
Sifri, S. A., Alshaikh, A., Bin-Abbas, B. S., Sheshah, E., Sabaan, F. S. A., Aldawish, M., Al-Dubayee, M., Alzaman, N. S., Aldahash, R., ALZAHRANI, S. H., et al. (2021) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2021.128028 · Cited by 4
Comparison of different models of structured self-monitoring of blood glucose in type 2 diabetes
Li, C.-L., Wu, Y.-C., Kornelius, E., Chen, Y.-J., Lin, Y.-T., Hsiao, H.-W., Peng, C.-H., Yang, Y.-S., & Huang, C.-N. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0082 · Cited by 2
The Behavior of Self-Monitoring of Blood Glucose and Glycemic Control in Taiwanese Population
Lu, C., Tseng, C., Liao, K. C.-W., Yang, H.-J., Chen, P., & Perng, M. (2022) · Endocrines · doi:10.3390/endocrines3020019 · Cited by 3
Changes in skeletal muscle in diabetes mellitus
Shatskaya, O. A., Bondarenko, I. Z., & Kushnarenko, S. S. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-376 · Cited by 2
Dubinina, I. I., Берстнева, С. В., Баранов, В. В., et al. (2016) · Diabetes Mellitus · doi:10.14341/dm7637 · Cited by 2
Nishimura, A., Harashima, S., Hosoda, K., & Inagaki, N. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0457-6 · Cited by 2
Ampudia‐Blasco, F. J., Ugarte, E., Chico, A. I., García-Alemán, J., & Galan-Barroso, M. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221087270 · Cited by 3
Remote health monitoring services in nursing homes
Kim, J., Kim, H., Im, S. I., et al. (2023) · Kosin Medical Journal · doi:10.7180/kmj.22.131 · Cited by 2
Priorities of self-monitoring of glycemia: an important component of successful diabetes management
Biryukova, E. V., & Викторович, Ш. М. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-202 · Cited by 2
Parkin, C. G. (2019) · AADE in Practice · doi:10.1177/2325160319861447 · Cited by 2
Self-citationPESSOAS QUE CONVIVEM COM FERIDAS: UMA REFLEXÃO TEÓRICA
Chavaglia, S. R. R., Ohl, R. I. B., Contim, D., & Gamba, M. A. (2015) · Revista Família Ciclos de Vida e Saúde no Contexto Social · doi:10.18554/refacs.v3i2.1086 · Cited by 4
Petrov, A. V., Александровна, К. А., Suvorova, L. A., Strongin, L. G., Владимировна, Л. Д., & Петрович, Г. С. (2012) · Diabetes Mellitus · doi:10.14341/2072-0351-5516 · Cited by 2
“Наиболее крупными проспективными исследованиями, посвященными самоконтролю у пациентов с СД2, не получающих инсулин, на настоящее время являются исследования DiGEM (the Diabetes Glycaemic Education and Monitoring trial) и STEP (the Structured Testing Program study), проведенные в Великобритании и США.”
Mankovsky, B. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0200 · Cited by 2
“well-being of enrolled patients significantly improved in the ST group.(6) Another study, the ACCU-CHEK 360 View Study in India, in which patients were randomized according to ST (ACCUCHEK 360 View) or standard of care according to their specific preference, showed even stronger HbA1c reductions and a more pronounced…”
BackgroundAssessing glycaemic control with self-monitoring of blood glucose
Meetoo, D. D., McAllister, G., & West, A. (2012) · Practice Nursing · doi:10.12968/pnur.2012.23.7.352 · Cited by 2
Self-Monitoring of Blood Glucose in Glucagon-Like Peptide-1–Based Treatment Approaches
Schnell, O., & Felton, A.-M. (2013) · Diabetes Spectrum · doi:10.2337/diaspect.26.2.107 · Cited by 2
PDM-ProValue meets cardiovascular outcome trials in diabetes
Fritzen, K., & Schnell, O. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0815-3 · Cited by 2
Schweiger, D. Š., & Battelino, T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816714-4.00001-6 · Cited by 3
Евгеньевна, Р. Г. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-286-292 · Cited by 3
Accuracy of Two CE-Marked Blood Glucose Monitoring System Based on EN ISO 15197:2015
Kim, J.-H., Garo, M. L., Guerra, A., Paparo, M. T., & Russo, A. (2021) · Diabetology · doi:10.3390/diabetology2040021 · Cited by 2
Slugocki, M., Bialonczyk, D., & Özdener-Poyraz, A. E. (2018) · Journal of Pharmacy Technology · doi:10.1177/8755122518813889 · Cited by 2
7 th Annual Symposium on Self-Monitoring of Blood Glucose (SMBG), May 8–10, 2014, Helsinki, Finland
Parkin, C. G., Mlinac, A., & Hinzmann, R. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0239 · Cited by 2
“Numerous recent studies have shown that use of structured testing regimens improves glycemic control and other outcomes.(10,11) Although these studies provide strong support for the International Diabetes Federation guidelines through controlled and observational study designs, a recent commentary by Selker et al.”
ResultSelf-citationPsychosocial and Behavioural Aspects of Diabetes
Pouwer, F., & Speight, J. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch63 · Cited by 3
Nayeem, J., Chowdhury, H. A., Afroze, N., Mili, U. S., & Ali, L. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07619 · Cited by 1
“SMBG is now regarded as an invaluable tool in the management of diabetes and thus prevention of diabetic complications [11, 12, 13].”
BackgroundZelada, H., Recklein, C. L., & McGill, J. B. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2172_22 · Cited by 1
Cebada, A. B., Silva, J. B. Q., Escobar-Morreale, H. F., & Chávez, L. N. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.10.010 · Cited by 5
Lee, C. S., Antoniadou, M., Jaarsma, T., Riegel, B. J., & Westland, H. (2025) · International Journal of Nursing Studies Advances · doi:10.1016/j.ijnsa.2025.100476 · Cited by 6
Pharmacoeconomics of Pharmacogenetics within the Context of General Health Technology Assessments
Postma, M. J., Boersma, C., Vegter, S., et al. (2013) · Pharmacogenomics · doi:10.1016/b978-0-12-391918-2.00012-3 · Cited by 1
Monnier, L., Colette, C., & Wojtusciszyn, A. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70329-7 · Cited by 1
Calidad de la asistencia a los pacientes con diabetes mellitus tipo 2 en España
Soriguer, F., & de Adana, M. S. R. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2011.09.030 · Cited by 1
長谷川, 美., Sasaki, H., Hara, M., & Murayama, N. (2012) · Food and Nutrition Sciences · doi:10.4236/fns.2012.39158 · Cited by 1
Maran, A., Tschoepe, D., Mauro, M. D., Fisher, W. A., Loeffler, K., Vesper, I., Bloethner, S., Mast, O., Weissmann, J., Amann-Zalán, I., et al. (2014) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2014.08.003 · Cited by 3
Self-citationCRANSTON, I. C., & Nicholson, E. (2014) · Practical Diabetes · doi:10.1002/pdi.1850 · Cited by 1
Structured educational model for SMBG: A model for primary care delivery
Edwards, R. (2013) · British Journal of Healthcare Management · doi:10.12968/bjhc.2013.19.11.526 · Cited by 1
Integrating Chronic Care into Family Practice: Blending the Paradigms
Tetrick, D. L., & Parkin, C. G. (2013) · Clinical Diabetes · doi:10.2337/diaclin.31.1.10 · Cited by 1
Self-citationDiabetestechnologie: Stand der Dinge
Heinemann, L. (2012) · Der Diabetologe · doi:10.1007/s11428-011-0855-0 · Cited by 1
Kang, B., & Cho, J. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.2.115 · Cited by 1
“Therefore the ability to measure and record glucose levels by themselves when needed in daily life is a very important part of appropriate diabetes management [1-5].”
BackgroundAdeleye, O., Ogbera, A. O., Ugwu, E. T., & Brodie-Mends, A. (2019) · The Open Diabetes Journal · doi:10.2174/1876524601909010001 · Cited by 1
Accuracy Evaluation of Five Blood Glucose Monitoring Systems in Patients from Different Departments
Li, X., Zheng, S., Pan, S., Yan, T., Di, J., Yang, Y., & Cheng, J. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0855-3726 · Cited by 4
Seufert, J., Pfohl, M., Borck, A., Bramlage, P., & Siegmund, T. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-00999-y · Cited by 1
Boynton, M. H., Donahue, K. E., Richman, E. L., Johnson, A., Leeman, J., Vu, M. B., Rees, J. R., & Young, L. (2022) · Clinical Diabetes · doi:10.2337/cd21-0141 · Cited by 2
Lamster, I. B., Bruno, M., & Touger-Decker, R. E. (2014) · Springer eBooks · doi:10.1007/978-1-60761-490-6_11 · Cited by 1
Al‐Worafi, Y. M. (2022) · CRC Press eBooks · doi:10.1201/9781003230458-20 · Cited by 1
Mungrue, K. (2014) · International Journal of Diabetes and Clinical Research · doi:10.23937/2377-3634/1410002 · Cited by 3
“On the other hand recent studies utilizing SMBG as an integral component of diabetes care showed improvements in mean glucose [15-19], glycemic variability [15] metabolic risk factors [17], depression and diabetes-related distress [20], and health behaviors.”
BackgroundParkin, C. G., Homberg, A., & Hinzmann, R. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0325 · Cited by 3
Self-citationLeyland, R., & Freedman, D. B. (2016) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563216631774 · Cited by 1
Hissa, M. N. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0180-2 · Cited by 1
Diabetes Management according to Blood Glucose Measurement Trend
Jung, J. (2017) · Journal of Korean Diabetes · doi:10.4093/jkd.2017.18.1.37 · Cited by 1
“한편 SMBG를 당뇨병 치료의 필수 요소로 활용한 최근의 연구들에서는 혈당강하제를 복용하는 제2형 당뇨병 환자 에서도 SMBG가 당화혈색소를 감소시키고 혈압, 콜레스 테롤 등의 대사 위험인자, 건강 행위들을 변화시키는 것으 로 보고되었다[4-6].”
Caring for people with diabetes: A fresh look at an old disease
Funnell, M. M., Kloss, K. A., & Nwankwo, R. B. (2022) · Nursing · doi:10.1097/01.nurse.0000884536.18596.9e · Cited by 3
Johnson, S. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397045-9.00031-8 · Cited by 1
Xie, Z. (2016) · Peter Lang eBooks · doi:10.3726/978-3-0351-0938-2/11 · Cited by 1
Giordanengo, A., Torsvik, T., Woldaregay, A. Z., Grøttland, A., Årsand, E., Hartvigsen, G., & Hansen, A. H. (2019) · doi:10.2196/preprints.14002 · Cited by 1
Parsimonious model for blood glucose level monitoring in type 2 diabetes patients.
Zhao, F., Fen, Y., Wen, J., Yan Fang, D. U., Li, C. L., & Li, G. W. (2014) · PubMed · doi:10.3967/bes2014.086
Veras, V. S. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2014.tde-20052014-192808
Glycemic treatment of diabetes mellitus
Kaur, H., & Weinstock, R. S. (2014) · Wiley eBooks · doi:10.1002/9781118887837.ch4
Mbue, N. D. (2013) · Digital Commons-TMC (Texas Medical Center)
Suvorova, L. A., Petrov, A. V., & Strongin, L. G. (2013) · Diabetes Mellitus · doi:10.14341/dm2013452-57
González, A. S., Fernández, N. Q., López, A. P., Garzón, R. D., Fernández, M., & Barberá-Comes, G. (2015) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2015.01.003
Espino, J. D. (2012) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(12)70338-9
The impact of steroids on diabetes control and management
Bates, C. (2011) · Practice Nursing · doi:10.12968/pnur.2011.22.9.472
Technologie ter optimalisatie van interventies en behandelresultaten bij kinderen met diabetes
Markowitza, J. T., Harringtona, K. R., & Laffel, L. M. (2014) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-014-0022-5
Vázquez, C. (2013) · Avances en Diabetología · doi:10.1016/j.avdiab.2013.03.002
Surveillance du contrôle de la glycémie
Berard, L., Blumer, I. R., Houlden, R. L., Miller, D. B., & Woo, V. C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.037 · Cited by 1
Sahnan, A., & Simpson, S. H. (2015) · American Journal of Pharmaceutical Education · doi:10.5688/ajpe79105
González, A. S., Fernández, N. Q., López, A. P., Garzón, R. D., Fernández, M., & Barberá-Comes, G. (2015) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2015.01.010
Schnell, O., Alawi, H., Battelino, T., Ceriello, A., Diem, P., Felton, A.-M., Harno, K., Satman, İ., & Vergès, B. L. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814534366
On the Bus or Under the Bus? The Current Healthcare System is Endangering Elderly Diabetes Patients
Parkin, C. G. (2015) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2015.02.00028
Self-citationParkin, C. G. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700420
“J Diabetes Sci Technol 2013;7(4):979–982 ORIGINAL ARTICLE”
Self-citationMizuno, M., Shimizu, Y., Seto, N., Kyouko, U., Masaki, H., Hatanaka, A., Okura, M., & Nakahama, T. (2015) · International Diabetes Nursing · doi:10.1080/20573316.2015.1103436
“Previous studies have demonstrated the effectiveness of SMBG for Type 2 diabetes patients who are not using insulin,(7,13) some have also provided evidence that integrating BGPM concepts into patient support can improve blood glucose control with the requirement of relatively fewer measurements of blood glucose levels…”
BackgroundHilfsmittel erleichtern persönliche Ausrichtung
Pampel, S. L. (2014) · Info Diabetologie · doi:10.1007/s15034-014-0564-z
Hightech allein schützt nicht vor Zucker-Talfahrt: Optimale Blutzuckerkontrolle
Oberhofer, E. (2012) · CME · doi:10.1007/s11298-012-0304-z
9th Annual Symposium on Self-Monitoring of Blood Glucose, April 28–30, 2016, Madrid, Spain
Parkin, C. G., Homberg, A., & Hinzmann, R. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0336
Self-citationSelf-monitoring of blood glucose: Is it justified?
Meetoo, D. D., Ochieng, B., Wong, L., & Fatani, T. (2016) · Nurse Prescribing · doi:10.12968/npre.2016.14.sup10.s10
Type 2 Diabetes Melittus–A Pathology on the Rise How do we Monitor it?
Lucia, F. E. S. M. (2013) · Pharmaceutica Analytica Acta · doi:10.4172/2153-2435.1000e160
Self-control – once more about the most important things
Meleshkevich, T. A., Shevchenko, M. E., Luchina, E., Popov, P. S., & Slonimskaya, G. A. (2016) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2016-17-138-142
Regular Evaluation for Patients with Diabetes Mellitus
Koo, B. K. (2016) · Journal of Korean Diabetes · doi:10.4093/jkd.2016.17.4.238
Informing the Design of a Smartphone-Based Telemonitoring System for Multiple Chronic Conditions
Sultan, M. (2016) · TSpace (University of Toronto)
Amante, D. J. (2016) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2rc7d
Clinical Aspects of Testing for Diabetes Mellitus
Wei, N. J. (2017) · Point of Care The Journal of Near-Patient Testing & Technology · doi:10.1097/poc.0000000000000118
Winskill, T. J. (2016) · Cited by 1
Diabète de type2: antidiabétiques oraux
Monnier, L., & Colette, C. (2017) · doi:10.1016/b978-2-294-74646-8.00009-2
Qualitative study on nursing processes to support blood glucose pattern management in Japan
Shimizu, Y., Mizuno, M., Uchiumi, K., Seto, N., & Masaki, H. (2017) · International Diabetes Nursing · doi:10.1080/20573316.2017.1402421
Psychological Distress Predicts HbA1c Trajectories among Type 1 Diabetic Adolescents
Ortíz, M. S., & Wiley, J. F. (2018) · Universitas Psychologica · doi:10.11144/javeriana.upsy17-3.pdpt
“In fact, previous studies have reported that immediate feedback has positive effects on Type 1 diabetes metabolic control (Li, Zhou, Chen, Song, & Xue, 2012; Polonsky et al., 2011).”
BackgroundDésordres glycémiques et complications diabétiques : physiopathologie
Monnier, L., & Colette, C. (2014) · Elsevier eBooks · doi:10.1016/b978-2-294-73954-5.00009-3
Glycemic Profiling in Patients with Drug-Naïve Type 2 Diabetes by Continuous Glucose Monitoring
Mori, H., Okada, Y., Kawaguchi, M., Otsuka, T., Miyazaki, M., Sonoda, S., Sugai, K., Uemura, F., Tanaka, K., Hajime, M., et al. (2018) · Journal of UOEH · doi:10.7888/juoeh.40.287
Point-of-care testing in diabetes management
Cozma, A., Vonica, C. L., Sitar-Tăut, A., & Fodor, A. (2019) · Revista română de medicină de laborator · doi:10.2478/rrlm-2019-0014
“Moreover, regular SMBG use in non-insulin treated patients also has a favorable impact on glycemic control (11, 12).”
BackgroundLifestyle intervention strategies for diabetes management
Tay, J., & Tay, J. (2016) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · doi:10.25909/5b63b9ac0685f
Tools of Self-Care: Self-Monitoring of Blood Glucose and Tele-Health Resources
Ginsberg, B. H. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_27
Surveillance du contrôle de la glycémie
(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.03.410
Nervo, A., Fracchia, A. C., Ragni, A., D’Angelo, V., Arvat, E., & Gallo, M. (2020) · Journal of Public Health · doi:10.1007/s10389-020-01200-7
McMorrow, R., Thuraisingam, S., Furler, J., & Manski-Nankervis, J.-A. E. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.08.001 · Cited by 2
Cost-Effectiveness of Monitoring Metabolic Control
Smokovski, I. (2020) · Springer eBooks · doi:10.1007/978-3-030-51469-3_5 · Cited by 1
Nedogoda, S. V., Salasyuk, A. S., Barykina, I. N., & Khripaeva, V. Y. (2013) · Cardiosomatics · doi:10.26442/cs45020
Shatskaya, O. A., Bondarenko, I. Z., & Kukharenko, S. S. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-238-244
John, A. M., Francis, A. K., Joseph, J. N., Joseph, M., & David, A. (2021) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-021-01001-y
Psychological and Behavioural Aspects of Type 2 Diabetes Management
Skinner, T. C., & Speight, J. (2022) · doi:10.1093/med/9780198870197.003.0260
Metadata
- Authors
- Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S.
- Affiliations
- University of California San Diego (US)
- University of California, San Francisco (US)
- Endeavor Health (US)
- Mid America Diabetes Associates, Wichita, Kansas
- Health Management Resources, Carmel, Indiana
- Biostat International, Tampa, Florida
- Roche Diagnostics, Indianapolis, Indiana
- Corresponding author
- Parkin, Christopher G.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 262-267
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024331
- OpenAlex
- W2102487069
- Semantic Scholar
- 074343a0d8101d85936aedd3d5e7285d19afe6d6
- Cited by
- 429
- References
- 26
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 18 · 2023: 15 · 2022: 20 · 2021: 27 · 2020: 21 · 2019: 26 · 2018: 28 · 2017: 25 · 2016: 47 · 2015: 37 · 2014: 31 · 2013: 44 · 2012: 43
- FWCI
- 37.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 2 diabetes, glycemic control, HbA1c, insulin-naive patients, glycemic variability, treatment intensification, general well-being, primary care
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Patient Education as Topic, Patient Participation, Primary Health Care, Prospective Studies, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.